We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Indivior has entered a strategic partnership and an exclusive option and licence agreement with France-based Aelis Farma for worldwide rights to the latter’s lead compound, AEF0117.